Viewing Study NCT01582295


Ignite Creation Date: 2025-12-24 @ 2:09 PM
Ignite Modification Date: 2025-12-27 @ 9:58 PM
Study NCT ID: NCT01582295
Status: COMPLETED
Last Update Posted: 2017-05-25
First Post: 2012-04-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module